# Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function

Study · id `cardio:ct-nct03082014` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03082014](<https://clinicaltrials.gov/study/NCT03082014>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03082014

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: High blood pressure; Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 101 participants.

## Technical summary

Registry record NCT03082014. Randomized; single masking; primary purpose treatment. Start 2018-02-22 (actual); primary completion 2022-07-28 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 101 participants (enrolled count; ClinicalTrials.gov record NCT03082014, source copy `cardio:ctgov-nct03082014-2023-03-09`, retrieved 2026-10-26)
- Started: 2018-02-22 (actual) (ClinicalTrials.gov record NCT03082014, source copy `cardio:ctgov-nct03082014-2023-03-09`, retrieved 2026-10-26)
- Primary completion: 2022-07-28 (actual) (ClinicalTrials.gov record NCT03082014, source copy `cardio:ctgov-nct03082014-2023-03-09`, retrieved 2026-10-26)
- Completion: 2022-07-28 (actual) (ClinicalTrials.gov record NCT03082014, source copy `cardio:ctgov-nct03082014-2023-03-09`, retrieved 2026-10-26)
- Countries: Germany; Netherlands; United Kingdom (ClinicalTrials.gov record NCT03082014, source copy `cardio:ctgov-nct03082014-2023-03-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03082014-2023-03-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function
- Acronym: TREAT-SVDs
- Condition: Cerebral Small Vessel Diseases
- Intervention (Drug): Amlodipine
- Intervention (Drug): Losartan
- Intervention (Drug): Atenolol
- Lead sponsor: Ludwig-Maximilians - University of Munich
- Lead sponsor class: OTHER
- Collaborator: University of Edinburgh
- Collaborator class: OTHER
- Collaborator: Maastricht University Medical Center
- Collaborator class: OTHER
- Collaborator: UMC Utrecht
- Collaborator class: OTHER
- Collaborator: University of Oxford
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Cerebral small vessel disease (`cardio:cerebral-small-vessel-disease`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Amlodipine (`cardio:amlodipine`)
- Registry intervention name matches this record: Losartan (`cardio:losartan`)
- Registry intervention name matches this record: Atenolol (`cardio:atenolol`)
- Registry lists this organization as the lead sponsor: Ludwig-Maximilians - University of Munich (`cardio:org-ludwig-maximilians-university-of-munich`)
- Registry lists this organization as a collaborator: University of Edinburgh (`cardio:org-university-of-edinburgh`)
- Registry lists this organization as a collaborator: Maastricht University Medical Center (`cardio:org-maastricht-university-medical-center`)
- Registry lists this organization as a collaborator: UMC Utrecht (`cardio:org-umc-utrecht`)
- Registry lists this organization as a collaborator: University of Oxford (`cardio:org-university-of-oxford`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of blood pressure-lowering agents on microvascular function in people with small vessel diseases (TREAT-SVDs): a multicentre, open-label, randomised, crossover trial (`cardio:pubmed-37863608`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 9083df52857d603ad2b879f4b4c65f0495878ebcd38ccad2b48272a5d14bde42
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
